CKD Prevention Program Protocol

Similar documents
The National Kidney Foundation (NKF) is pleased to submit testimony regarding the impact of

STATEMENT OF THE NATIONAL KIDNEY FOUNDATION SUBMITTED TO THE HOUSE COMMITTEE ON APPROPRIATIONS;

Difference in practical dialysis therapy between East Asia and US/EU

CKD Screening in Developing Countries. The case of Jalisco, Mexico.

Jai R adhakrishnan, Radhakrishnan, MD Columbia University

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Applying clinical guidelines treating and managing CKD

Section K. Economic costs of ESRD. Vol 3 esrd. pg 731. K tables

United States Renal Data System (USRDS) International Data Collection Form

The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century?

morbidity & mortality

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources

Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data

Addressing Chronic Kidney Disease in Texas: A Work in Progress

CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017

Cardiovascular disease profile

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1

Global End Stage Renal Disease (ESRD) Market With Focus on Dialysis Market ( Edition) July 2017

Chronic kidney disease-what can you do and when to refer?

REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange

2017 USRDS ANNUAL DATA REPORT KIDNEY DISEASE IN THE UNITED STATES S611

Zhao Y Y et al. Ann Intern Med 2012;156:

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

Professor Suetonia Palmer

Palliative and End of Life Care in End Stage Renal Disease

Acceptance onto dialysis guidelines: St George Hospital

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

Wendy Washington & Anne Graham. Nephrology Nurse Practitioners

Information for patients with kidney disease attending the Low Clearance Clinic

Patient Description and Diagnosis: Sarah Jones is a 50-year-old female, 5 4, 131

CKD Conservative care and preparation for dialysis Dr Anirudh Rao Registrar, UK Renal Registry. UK Renal Registry 2013 Annual Audit Meeting

Kidney Failure- Are you at risk?? ( 腎功能衰竭 - 你是在高危險群嗎?)

East London Community Kidney Service

Living Donor Paired Exchange (LDPE)

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

ASN s Legislative Priorities for 2010

New Treatments for ADPKD how close are we?

What Happened? 3/20/2017. Changing Lives and Making a Difference: Home Hemodialysis Stories. Brigitte Schiller, MD, FACP, FASN

Chronic Kidney Disease

1. Default Section. 1. Gender: 2. Credentials (mark all that apply):

Objectives At the end of the session, participants will be able to:

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

CKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College

The Renal Physicians Association Quality Improvement Registry

Concept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA

END - STAGE RENAL DISEASE AND KIDNEY REPLACEMENT THERAPY IN BACHMAI HOSPITAL HANOI - VIETNAM

Improving global access to integrated ESKD care. David Harris 01/10/17

Dialysis versus Supportive Care

Early Detection of Chronic Kidney Disease (CKD)

17 th Annual Meeting of JSHDF, Sept 3-4, 2011

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Your Kidney Health. Your Choices. Chronic Kidney Disease

Geriatric Nephrology. Murtener Tage

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

THE ECONOMIC IMPACT OF END-STAGE KIDNEY DISEASE IN AUSTRALIA PROJECTIONS TO 2020

DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for

Department of Nephrology

Chapter 25: Interactions of Dialysis Teams With Geriatricians

USRDS UNITED STATES RENAL DATA SYSTEM

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner

Chapter 5: Acute Kidney Injury

Meeting the Guidelines for End-of-Life Care

Epidemiology of CKD in Children

SAMPLE SYSTEM INNOVATION/QUALITY IMPROVEMENT Activities Sections. Alicia Neu, M.D. December 1, 2011

Renal Transplantation: Allocation challenges and changes. Renal Transplantation. The Numbers 1/13/2014

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

Building a clinical service for children with CKD in a developing country

Renalyx Extending Renal Health

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Management of early chronic kidney disease

Translating the KidneyWise Clinical Toolkit into an Electronic Medical Record Decision Support Tool

Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications

Management of Early Kidney Disease: What to do Before Referring to the Nephrologist

Adding Insult to Injury. Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London

National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC)

Update on HIV-Related Kidney Diseases. Agenda

ADVANCE CARE PLANNING FOR KIDNEY PATIENTS: THE IMPORTANCE OF AN ONGOING DISCUSSION

Preservation of Veins and Timing for Vascular Access

NorWest Mobile Diabetes and Kidney Screening and Intervention Project. Cindy Peters Primary Care Nurse

2015 Investor Conference

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

UNITED NATIONS HIGH-LEVEL MEETING ON NCDs A CALL TO ACTION ON KIDNEY DISEASE. Advancing Nephrology Around the World

Stages of Chronic Kidney Disease (CKD)

THE CONSERVATIVE CARE PATHWAY

Maolynne Miller Paediatric Nephrologist UHWI Jamaica Kidney Kids Foundation/ International Paediatric Nephrology Association 1st Jamaican Paediatric

Chapter 2: Identification and Care of Patients With CKD

It is important upfront to realize and believe that, like many adults,

year in review 2015/2016 manitoba renal program Winnipeg Regional Health Authority manitoba renal program

Chapter 2: Identification and Care of Patients with CKD

New global report highlights silent epidemic of kidney disease and neglect of treatment and prevention in all countries

UNIVERSITY OF CALGARY. diabetes mellitus. Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES

Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

Is a kidney transplant right for me?

Niagara Health Quality Coalition Employers Leading The Way In Health Care Quality

Cost-effectiveness of tolvaptan (Jinarc ) for the treatment of autosomal dominant polycystic kidney disease (ADPKD)

KDIGO Controversies Conference on Challenges in the Conduct of Clinical Trials in Nephrology

Chronic Kidney Disease. Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital

Transcription:

CKD Prevention Program Protocol Taiwan Pathway as an example I. Understanding problems and situations of ESRD/CKD in Taiwan 1. Understanding the ESRD/CKD Burden 1) National Dialysis Registry since 1987 by Taiwan Society of Nephrology (TSN) 2) CKD prevalence estimation by epidemiology study (National and Local) 3) Impacts on medical economics and financial burdens of National Health Insurance (NHI launched since 1995) 2. Identifying risk factors and target populations through national and local studies 1) Patients with diabetes, hypertension 2) Patients with family history of chronic kidney disease (CKD) 3) Individuals receiving potentially nephrotoxic drugs, herbs or substances or taking indigenous medicine 4) Individuals older than 65 years II. Plans and actions taken in strategy consideration and time sequence 1. Facts exposure and collaboration with the government 1) Report ESRD data to academic organization for international comparison (USRDS) - 2001 2) Exposure to media and legislators, promote government concern as an important public health issue - 2001 3) Collaboration with Department of Health (DOH)- TSN President and Committee of Chronic Diseases Prevention, DOH -2001 4) Active participation in policy making within government institutes (National Bureau of Health Promotion (NBHP) and Bureau of National Health Insurance (BNHI)) - 2002 2. Organize CKD Prevention Committee within Taiwan Society of Society - 2003 1) Design overall CKD prevention project at national perspectives. 2) Play the pivot role as opinion, education, and action leader

3) Arrange CKD educational programs extensively at regional and annual meeting 4) Design and initiate training course of multidisciplinary CKD care for nephrologists, CKD nurse educators, and renal dietitians 5) Set up project for organizing the CKD prevention institutions as the key unit of CKD patient care, early prevention measure, and public education at hospital level. 3. Action taken for patient education and multidisciplinary team care in CKD prevention institutions through Taiwan CKD Prevention Project- 2002 1) Pilot project of Integrated Care of CKD from major hospitals- 2002 (NBHP) 2) Project expansion to include more CKD Prevention Organizations (rolled out to clinics)-2003-present (NBHP+TSN) 3) CKD Information System for register and case management 2005 (NBHP) 4) Project of Integrated Care for Pre-ESRD patients (CKD stage 3b, 4, 5) and screening for high risk patients with reimbursement from National Health Insurance-2007-present (BNHI) 5) Project of Care for Early CKD patients (CKD 1, 2, 3A), extension to general medicine discipline 2011- present (BNHI) III. Collaboration among Government, Academic Societies, and other non-government Organizations 1. Public propaganda 1) Use extensive public media for educating CKD concept and promoting prevention action 2) Initiate the public health promotion activity of Taiwan Kidney Day 2005 (one year ahead of World Kidney Day) 3) Continue public propaganda to wherever, whenever, and whoever strategy 2. Risk factors reduction through National Health Promotion program by Department of Health 1) Diabetes control 2) Hypertension control 3) Hyperlipidemia control 4) Prohibition of aristolochic acid containing herbs since 2003 3. CKD Early Detection through adult and elderly physical check-up project 1) Report egfr from serum creatinine and urine protein from dipstick test 2) Make CKD staging accordingly

3) Refer subject detected as CKD to health care system IV. Outcome Monitor and Future Goals 1. Outcome measures 1) Long term goals-reduction of ESRD incidence as final goal 2) Short term goals-improving CKD quality of care a. Reduction of the incidence of emergent dialysis b. Increased rate of prepared vascular access before dialysis c. Increased penetration of PD, a less expensive treatment in Taiwan d. Promote renal transplantation, a difficult concept in Taiwan e. Slowing the renal progression rate by medical and multidisciplinary care f. Improved CKD quality of care based on various clinical parameters g. Reduction of medical expenses before and after initiation of dialysis 3) The rising incidence rate of ESRD began to decline from 2006 to 2009 2. Future goals: set by DOH 2011, to work with TSN. a. Decrease the dialysis incidence rate by 2%/year, to move out of the ranking of 5 th world highest incidence in 10 years b. Keep good dialysis survival rate--5-year survival rate of dialysis must be kept higher than EDTA registry c. Increase numbers of new renal transplants--15% increment in 5 years d. Increase penetration rate of peritoneal dialysis--20% of incident dialysis cases, 13% of prevalent dialysis cases as PD

Trend of Prevalence and Incidence of Dialysis ESRD Patients 2500 2000 1500 1000 500 0 2219 2288 Prevalence rate Incidence rate 2120 1891 1999 National Health Insurance 1765 1636 1371 1497 1235 2.5x 988 1113 605 508 427 352 859 715 6.5x 376 391 402 405 435 420 415 110 129 146 168 182 232 247 262 277 310 334 2.1x 3.8x TSN Renal Registry 1990 ~ 2007 Calendar year Diabetes became the leading cause of ESRD Increased incidence of aged group after launching of NHI 50% 40% 30% 20% 10% 0% Chronc GN TIN 199019921994199619982000200220042006 Canlendar Year 3000 2500 2000 1500 1000 500 0 Incidence rate (pmp) All Patients Age = 75 Age = 65-74 Age = 45-64 Age = 20-44 Age = 0-19 1990 19921994 199619982000 200220042006 Calendar Year Diabetes, aged, and health insurance are majors for increase of ESRD. TSN Renal Registry 1990~2001 Yang & Hwang, NDT, 2008

Multidisciplinary Care Team for CKD Patients Clinical Flow Chart for CKD Out-Patient